FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040489008> ?p ?o ?g. }

• W2040489008 endingPage "310" @default.
• W2040489008 startingPage "303" @default.
• W2040489008 abstract "<h3>Background and Objectives:</h3> Voltarol for injection (a diclofenac sodium formulation employing polyethylene glycol and benzyl alcohol [PG-BA] as excipients) is marketed in Europe but not in North America. A suspension, PG-BA diclofenac sodium, requires preparation for each patient and slow IV infusion to minimize venous irritation. Dyloject, a novel diclofenac formulation, employs hydroxypropyl β-cyclodextrin (HPβCD) to solubilize diclofenac in a small volume. We compared the efficacy and safety of an IV HPβCD diclofenac sodium bolus, a 30-minute PG-BA diclofenac sodium infusion, and placebo in post–molar extraction pain. <h3>Methods:</h3> A total of 155 adult patients were randomized to receive HPβCD diclofenac sodium 75 mg, PG-BA diclofenac sodium 75 mg, or placebo. Primary endpoints were superiority of HPβCD diclofenac sodium to placebo and noninferiority of HPβCD diclofenac sodium to PG-BA diclofenac sodium with respect to total pain relief over 4 hours (TOTPAR4) on a 0 to 100-mm visual analog scale (VAS). Secondary endpoints included categorical TOTPAR4, VAS and categorical TOTPAR up to 8 hours, other measures of pain intensity and relief, patient global evaluation, and time to rescue medication. <h3>Results:</h3> HPβCD diclofenac sodium had efficacy superior to both placebo and PG-BA diclofenac sodium. At 15 minutes, more patients given HPβCD diclofenac sodium than PG-BA diclofenac sodium reported 30% reduction in pain intensity (52% vs. 21%, <i>P</i> = .0022). Both diclofenac products had a 6-hour duration of effect and were well tolerated. Patient global evaluations of HPβCD diclofenac sodium were high, superior to placebo, and similar to PG-BA diclofenac sodium. The adverse event (AE) incidence was similar for HPβCD diclofenac sodium and PG-BA diclofenac sodium, except that in the current trial and in integrated safety results from the present and prior studies, phlebitis was more common with PG-BA diclofenac sodium. No cardiac or renal AEs or gastrointestinal bleeding were reported or observed. <h3>Conclusions:</h3> IV bolus HPβCD diclofenac sodium produced analgesia more quickly than, and with equal duration as, the 30-minute PG-BA diclofenac sodium infusion. Pooled data on thrombophlebitis from the present investigation and our prior studies of the novel formulation indicate this adverse effect is less frequent and less severe with HPβCD diclofenac sodium than with PG-BA diclofenac sodium." @default.
• W2040489008 created "2016-06-24" @default.
• W2040489008 creator A5014972646 @default.
• W2040489008 creator A5016430100 @default.
• W2040489008 creator A5028113999 @default.
• W2040489008 creator A5051964825 @default.
• W2040489008 creator A5059173323 @default.
• W2040489008 creator A5068497846 @default.
• W2040489008 creator A5084221488 @default.
• W2040489008 creator A5091033546 @default.
• W2040489008 date "2007-07-01" @default.
• W2040489008 modified "2023-09-27" @default.
• W2040489008 title "Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain" @default.
• W2040489008 cites W1685046566 @default.
• W2040489008 cites W1972886293 @default.
• W2040489008 cites W1982245802 @default.
• W2040489008 cites W1986765230 @default.
• W2040489008 cites W2026814137 @default.
• W2040489008 cites W2036406575 @default.
• W2040489008 cites W2043177715 @default.
• W2040489008 cites W2044287825 @default.
• W2040489008 cites W2047173081 @default.
• W2040489008 cites W2069068496 @default.
• W2040489008 cites W2072957227 @default.
• W2040489008 cites W2079371293 @default.
• W2040489008 cites W2080745496 @default.
• W2040489008 cites W2089670500 @default.
• W2040489008 cites W2093526427 @default.
• W2040489008 cites W2132309748 @default.
• W2040489008 cites W2139776244 @default.
• W2040489008 cites W2145368255 @default.
• W2040489008 cites W2145743045 @default.
• W2040489008 cites W2152261628 @default.
• W2040489008 cites W2157662040 @default.
• W2040489008 cites W2398295834 @default.
• W2040489008 cites W2486584027 @default.
• W2040489008 cites W569583279 @default.
• W2040489008 doi "https://doi.org/10.1016/j.rapm.2006.07.010" @default.
• W2040489008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17720114" @default.
• W2040489008 hasPublicationYear "2007" @default.
• W2040489008 type Work @default.
• W2040489008 sameAs 2040489008 @default.
• W2040489008 citedByCount "21" @default.
• W2040489008 countsByYear W20404890082012 @default.
• W2040489008 countsByYear W20404890082014 @default.
• W2040489008 countsByYear W20404890082015 @default.
• W2040489008 countsByYear W20404890082016 @default.
• W2040489008 countsByYear W20404890082017 @default.
• W2040489008 countsByYear W20404890082018 @default.
• W2040489008 countsByYear W20404890082019 @default.
• W2040489008 crossrefType "journal-article" @default.
• W2040489008 hasAuthorship W2040489008A5014972646 @default.
• W2040489008 hasAuthorship W2040489008A5016430100 @default.
• W2040489008 hasAuthorship W2040489008A5028113999 @default.
• W2040489008 hasAuthorship W2040489008A5051964825 @default.
• W2040489008 hasAuthorship W2040489008A5059173323 @default.
• W2040489008 hasAuthorship W2040489008A5068497846 @default.
• W2040489008 hasAuthorship W2040489008A5084221488 @default.
• W2040489008 hasAuthorship W2040489008A5091033546 @default.
• W2040489008 hasConcept C142724271 @default.
• W2040489008 hasConcept C204787440 @default.
• W2040489008 hasConcept C27081682 @default.
• W2040489008 hasConcept C2779826273 @default.
• W2040489008 hasConcept C2908765736 @default.
• W2040489008 hasConcept C42219234 @default.
• W2040489008 hasConcept C71924100 @default.
• W2040489008 hasConcept C98274493 @default.
• W2040489008 hasConceptScore W2040489008C142724271 @default.
• W2040489008 hasConceptScore W2040489008C204787440 @default.
• W2040489008 hasConceptScore W2040489008C27081682 @default.
• W2040489008 hasConceptScore W2040489008C2779826273 @default.
• W2040489008 hasConceptScore W2040489008C2908765736 @default.
• W2040489008 hasConceptScore W2040489008C42219234 @default.
• W2040489008 hasConceptScore W2040489008C71924100 @default.
• W2040489008 hasConceptScore W2040489008C98274493 @default.
• W2040489008 hasIssue "4" @default.
• W2040489008 hasLocation W20404890081 @default.
• W2040489008 hasLocation W20404890082 @default.
• W2040489008 hasOpenAccess W2040489008 @default.
• W2040489008 hasPrimaryLocation W20404890081 @default.
• W2040489008 hasRelatedWork W1999035416 @default.
• W2040489008 hasRelatedWork W2015689899 @default.
• W2040489008 hasRelatedWork W2027514099 @default.
• W2040489008 hasRelatedWork W2066664366 @default.
• W2040489008 hasRelatedWork W2092936332 @default.
• W2040489008 hasRelatedWork W2120347698 @default.
• W2040489008 hasRelatedWork W2123236556 @default.
• W2040489008 hasRelatedWork W2187022211 @default.
• W2040489008 hasRelatedWork W2410963000 @default.
• W2040489008 hasRelatedWork W2417338034 @default.
• W2040489008 hasVolume "32" @default.
• W2040489008 isParatext "false" @default.
• W2040489008 isRetracted "false" @default.
• W2040489008 magId "2040489008" @default.
• W2040489008 workType "article" @default.